Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Targeting Stress-Induced Alcohol Relapse Risk With Doxazosin XL

NCT03398252 is registered in ClinicalTrials.gov with The University of Texas Health Science Center, Houston as lead sponsor.

NCT NCT03398252
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03398252 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Targeting Stress-Induced Alcohol Relapse Risk With Doxazosin XL
Lead sponsor
The University of Texas Health Science Center, Houston
Phase
Phase 1
Overall status
Withdrawn
Start date
May 12, 2022
Completion date
October 1, 2023
Enrollment
0 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

alcohol use disorder